glp-1 hair thinning Here's What You Can Do for Loss Due to GLP-1s How to Stop Hair Loss

REFERENCES British Menopause Society incretin therapies and HRT NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings

If GLP-1 therapy is initiated , a structured monitoring plan should include: Regular assessment of weight, BMI and nutritional status Monitoring of hydration and renal function, particularly if experiencing significant gastrointestinal symptoms For diabetes patients, appropriate retinopathy surveillance if glycaemic control improves rapidly (especially with semaglutide) [5] [11] Regular review of Crohn's disease activity using clinical and biochemical markers Remember that you are an active participant in your healthcare decisions, and your concerns and experiences should guide the treatment plan

GLP-1-related hair loss usually manifests as telogen effluvium 24 months after starting treatment or significant weight loss

Your healthcare team should provide hands-on training before your first dose